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ABSTRACT 
In this work, an efficient sample pretreatment method has been developed by combining salt induced–
homogenous liquid–liquid extraction, dispersive solid phase extraction, and dispersive liquid–liquid microextrac-
tion based on the solidification of floating organic droplet for the extraction of some widely used tricyclic anti-
depressant (TCA) drugs (nortriptyline, amitriptyline, desipramine, clomipramine, and imipramine) in human 
urine samples before their determination by high performance liquid chromatography–ultraviolet detection. In 
brief, the target analytes are first isolated from urine samples into acetonitrile (ACN) separated by adding a salt. 
Then the obtained ACN phase is treated with a mixture of appropriate sorbents to remove interfer-
ences. Afterward, the purified ACN is mixed with menthol as an extractant and rapidly injected into alkaline 
HPLC–grade water as a preconcentration step. Next, the obtained solution is placed in an ice bath and menthol 
collects on top of the solution after solidification. The solidified drop is then withdrawn and injected into separa-
tion system after dissolving in 10 µL ACN. Under the optimum experimental conditions, extraction recoveries 
and enrichment factors of the selected drugs ranged from 69–84 % and 345–420, respectively. The limits of de-
tection and quantification were obtained at the ranges of 0.22–0.31, and 0.71–1.1 µg L–1, respectively. The rela-
tive standard deviations of the proposed method were ≤ 6 % for intra– (n=6) and inter–day (n=4) precisions at a 
concentration of 10 µg L–1 (each drug). Finally, the suggested approach was applied to determine of TCA drugs 
in different patients' urine samples. The method could be applied in further TCAs pharmacokinetic and forensic 
studies. 
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INTRODUCTION 
Millions of people all over the world suf-
fer from a common mental disorder named 
depression. This disorder causes patients to 
experience serious problems such as de-
pressed mood, feelings of guilt, disturbed 
sleep, low energy, and loss of interest or 
pleasure. In the 1950s, antidepressants were 
developed which could elevate patients' 
mood. Antidepressants are commonly classi-
fied in two main groups: the monoamine ox-
idase inhibitors and TCAs (Parfitt and Mar-
tindale, 2002; Micó et al., 2006). TCAs are 
one of the oldest classes of antidepressants 
and impede the reuptake of serotonin and 
norepinephrine (Furlanut et al., 1993). The 
drug concentrations in biological fluids play 
a critical role in pharmacotherapies. This role 
is much more important in the case of TCAs, 
due to their narrow therapeutic range. So, 
improving of the sensitivity and detection 
limit of the analytical method is necessary to 
determine the concentrations of TCAs in bio-
logical fluids (plasma, serum or urine) in or-
der to obtain the best therapeutic concentra-
tion for effective control of pharmacotherapy 
and drug poisoning.  
Chromatographic techniques such as gas 
(Gupta et al., 1983; Yazdi et al., 2008) and 
liquid chromatography (Woźniakiewicz et 
al., 2008; Zheng et al., 2010) are suitable for 
these purposes. However, because of the 
complicated matrices of the biological sam-
ples and low concentration of the selected 
drugs in them, a selective preparation ap-
proach is required before their determination 
by chromatographic techniques. In the past 
years, solid phase extraction (SPE) and liq-
uid–liquid extraction were applied for the ex-
traction and preconcentration of the target 
analytes from different matrices. However, 
these methods require high volumes of sam-
ple and organic solvents and are environ-
mentally unfriendly and time–consuming 
(Yazdi and Amiri, 2010; Poole, 2003). Ho-
mogeneous liquid–liquid extraction (HLLE) 
is an extraction procedure in which analytes 
existing in a homogeneous solution are ex-
tracted into a water–immiscible solvent by 
adding a phase separation agent. Tempera-
ture adjusting, salt addition or pH adjustment 
are mostly used as the phase separation 
agents (Murata et al., 1972; Jain et al., 2015; 
Zhao et al., 2009; Tavakoli et al., 2008). The 
main disadvantage of HLLE–based methods 
is that they are not selective, which limits 
their application to simple, aqueous samples. 
In order to overcome this problem, a clean–
up step is often required for the removal of 
interfering substances such as organic acids, 
pigments, and sugars. Dispersive solid phase 
extraction (DSPE) is an efficient clean–up 
method which is based on SPE. But unlike 
SPE, in this method the sorbent is directly 
added to the extract without conditioning and 
pretreatment (Wu et al., 2011; Díez et al., 
2006). However, low enrichment factors 
(EFs) are achievable by performing HLLE. 
In recent years, different preconcentration 
microextraction methods including solid 
phase microextraction (Zhang et al., 1994) 
and liquid–phase microextraction (LPME) 
(Psillakis and Kalogerakis, 2003) have been 
introduced. In 2006, dispersive liquid–liquid 
microextraction (DLLME) was introduced as 
a novel mode of LPME (Rezaee et al., 2006). 
In DLLME, an appropriate mixture of an ex-
traction and a disperser solvent is rapidly in-
jected into an aqueous solution containing 
analyte. As a result, tiny droplets of the ex-
tractant are formed and the analytes are ex-
tracted into these drops. Although DLLME 
eliminates some of the problems of the tradi-
tional methods, toxic organic solvents like 
chloroform, carbon tetrachloride, chloroben-
zene, and etc. are required for this method, 
though much less than the traditional extrac-
tion methods. Later, a DLLME method 
based on the solidification of a floating or-
ganic drop (DLLME–SFO) was established 
by means of lighter than water solvents 
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(Leong and Huang et al., 2008). DLLME–
SFO is similar to conventional DLLME, ex-
cept that after centrifugation, floating phase 
on top of aqueous solution is solidified with 
the help of an ice bath. Solvents such as 1–
dodecanol, and 1–undecanol which possess 
melting points near to room temperature are 
commonly used in this method (Dai et al., 
2010). 
The purpose of the presented work is to 
introduce feasible, efficient, and green sam-
ple pretreatment approach based on the com-
bination of salt induced–HLLE (SI–HLLE) 
with DSPE as a clean–up step, and DLLME–
SFO using menthol as a safe solvent in order 
to extract of some TCAs from urine samples 
before their determination by high perfor-
mance liquid chromatography–ultraviolet de-
tector (HPLC–UV). The proposed method 
simultaneously possesses the advantages of 
SI–HLLE, DSPE, and DLLME–SFO. The 
use of menthol as an easily–accessible and 
green extractant in place of aromatic and 
halogenated solvents makes the approach 
eco–friendly. The effect of different parame-
ters on the extraction efficiency of the sug-
gested method were thoroughly studied and 
optimized. 
 
MATERIALS AND METHODS 
Reagents and solutions 
Nortriptyline and amitriptyline were pur-
chased from Daroupakhsh Company (Teh-
ran, Iran). Desipramine was a gift from Exir 
Pharmaceutical Company (Boroujerd, Iran). 
Clomipramine and imipramine were ob-
tained from Soha Pharmaceutical Company 
(Karaj, Iran). Sodium sulfate, sodium chlo-
ride, potassium chloride, ammonia (25 %), 
hydrochloric acid (37 %), acetone, dimethyl 
formamide (DMF), sodium hydroxide, and 
ammonium acetate were supplied from 
Merck (Darmstadt, Germany). Menthol with 
a purity of 98 % was also purchased from 
Merck. Primary–secondary amine (PSA), 
graphitized carbon black (GCB), and octade-
cylsilane (C18) sorbents were purchased from 
Agilent Technologies Company (Santa 
Clara, CA, USA). Methanol, acetonitrile 
(ACN), and HPLC–grade water were sup-
plied from Chemlab (Zedelgem, Belgium). A 
mixture stock solution of drugs was prepared 
in methanol with a concentration of 50 mg 
L–1 (each drug) and working standard solu-
tions were prepared daily by diluting the 
stock solution with HPLC–grade water.  
 
Apparatus 
Hewlett Packard 1090–II HPLC system 
(Palo Alto, CA, USA) equipped with a fixed 
wavelength UV–vis detector was used as the 
analytical instrument. Chromatographic sep-
aration of the analytes was carried out on an 
RP–C18 column obtained from Shimadzu 
(Kyoto, Japan) (15 cm × 4.6 mm i.d. with 
particles size of 5 µm). The mobile phase 
was a mixture of ammonium acetate (0.05 
M, adjusted at pH 5.5) –ACN (55:45, v/v) at 
a flow rate of 0.5 mL min–1 using an isocrat-
ic elution. Monitoring of the drugs was done 
at 230 nm. All injections were performed 
manually using a 10–µL sample loop. The 
HPLC system was controlled using Chem-
Station software. A Metrohm pH meter 
(model 654, Herisau, Switzerland), Hettich 
centrifuge (model D–7200, Kirchlengern, 
Germany), and an L46 vortex (Labinco, Bre-
da, Netherlands) were used in pH adjust-
ment, accelerating phase separation, and vor-
texing the samples, respectively. 
 
Samples 
Blank urine sample was obtained from a 
healthy volunteer who had not taken any 
drugs for at least one month. Three urine 
samples were obtained from three depressed 
female patients being treated with amitripty-
line (25 mg, twice in a day), clomipramine 
(50 mg, per day), and nortriptyline (25 mg, 
twice in a day), respectively. In addition, two 
other distinct blood and urine samples were 
obtained from two depressed male patients 
being treated with desipramine (25 mg, twice 
a day), and imipramine (25 mg, twice a day), 
respectively. The volunteers were well in-
formed of the study and signed written con-
sent forms. All of the samples were collected 
within 24 h from first oral administration. 
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All samples were collected in polypropylene 
vessels and stored at –20 °C until use. The 
urine samples were adjusted at pH 10.0 with 
the help of an ammoniacal buffer (0.5 M) 
and then subjected to the proposed method. 
 
Extraction procedure 
SI–HLLE 
Five mL ammoniacal buffer (0.5 M, 
pH=10) spiked with the investigated drugs 
(20 µgL−1, each drug) or the urine sample 
(see Samples) was transferred into a 10–mL 
glass test tube. Afterward, 2.0 mL ACN was 
added to it and a homogenous solution was 
obtained. Then 1.75 g sodium sulfate (35 %, 
w/v) was added to the homogenous solution 
and vortexed until it was dissolved complete-
ly. By this action, phase separation occurred 
and fine droplets of ACN containing the ex-
tracted analytes were formed and collected 
on the surface of aqueous phase (1.1 ± 0.05 
mL) after centrifuging for 5 min at 5000 
rpm.  
DSPE 
One mL of the ACN obtained from the 
previous step was removed using a 1–mL 
glass syringe and transferred into a 10–mL 
glass test tube containing 50 mg PSA, 25 mg 
GCB, and 50 mg C18. The solution was vor-
texed for 2 min and centrifuged at 5000 rpm 
for 5 min. Then the supernatant was removed 
and used in DLLME–SFO. 
DLLME–SFO 
The ACN phase obtained from the DSPE 
step was mixed with 35 µL menthol (extrac-
tion solvent) and rapidly injected into 5 mL 
ammoniacal buffer (adjusted at pH=10.0 and 
temperature of 40 °C) placed in a 10–mL 
glass test tube. By this action, fine droplets 
of menthol were formed and the target ana-
lytes were extracted into them. The solution 
was centrifuged at 5000 rpm for 5 min. Af-
terward, the solution was placed in an ice 
bath and the menthol was collected on top of 
the solution as a solid drop. This drop was 
transferred into a vial with a spatula and dis-
solved in 10 µL ACN. At last, the solution 
was injected into determination system. The 
developed method procedure is shown in 
Figure 1. 
 
Figure 1: Schematic procedure of the developed method 
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RESULTS AND DISCUSSION 
Optimization of SI–HLLE step 
Selection of extraction/disperser solvent type 
and volume 
In the present work, the extraction sol-
vent used in SI–HLLE step acts as a dispers-
er in the following preconcentration step 
(DLLME–SFO). Considering this fact, the 
selected solvent should meet the following 
criteria: (1) ability of a two–phase system 
formation after salt addition, (2) high extrac-
tion efficiency for the target drugs, (3) mis-
cibility with extractant used in DLLME–
SFO and aqueous phase, (4) density lower 
than water, and (5) low toxicity. Considering 
these properties, four organic solvents in-
cluding ACN, methanol, acetone, and DMF 
(2.0 mL each of them) were selected and 
tested in this step. The obtained results indi-
cated that only by using ACN is a two–phase 
system formed after the addition of sodium 
sulfate (30 %, w/v). Consequently, ACN was 
chosen in this step.  
ACN volume is another parameter that 
can influence the efficiency of the proposed 
method. To investigate this parameter, dif-
ferent volumes (1–3 mL with 0.5–mL inter-
vals) of ACN were evaluated. It is obvious 
that the initial volume of ACN can affect the 
volume of the separated phase after adding 
phase separation agent. According to the ob-
tained results, in the cases of 1.0, 1.5, 2.0, 
2.5, and 3.0 mL, the volume of the separated 
phase was 0.2, 0.5, 0.9, 1.2, and 1.5 mL, re-
spectively. In these experiments, 1 mL of the 
separated phase was removed and used in the 
next steps, except in the cases that lower 
than 2.5 mL of ACN was used and the vol-
umes of the collected phases were lower than 
1 mL. In those cases, all of the collected 
phase was removed and mixed with appro-
priate volumes of pure ACN in order to 
reach the final volume of 1 mL and was used 
in other cases. The experimental results in 
Figure 2 indicate that the extraction recover-
ies (ERs) of the selected drugs increased by 
increasing the volume of the ACN from 1.0–
2.0 mL and then slightly decreased between 
2.0 and 3.0 mL. Subsequently, 2.0 mL ACN 
was used in the next experiments. 
 
Figure 2: Selection of extraction/disperser solvent. Extraction conditions: aqueous sample volume, 5 
mL HPLC–grade water spiked with 20 µg L–1 of each analyte; extraction/disperser solvent, ACN; 
phase separation agent, sodium sulfate (30 %, w/v); aqueous phase pH value, 10.0; vortex time, 1 
min; sorbent (amount), PSA (50 mg); vortex time, 1 min; aqueous phase in DLLME–SFO, 5 mL 
HPLC–grade water; aqueous phase temperature (50 oC); aqueous phase pH, 10.0; extractant (vol-
ume), menthol (40 µL); centrifugation rate and time 5000 rpm and 5 min; and aqueous phase pH val-
ue, 10.0. 
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Selection of type and concentration of phase 
separation agent 
In SI–HLLE method, the type and con-
centration of salt play key roles. In most cas-
es, salt addition decreases the solubility of 
the analytes in the sample solution and sim-
ultaneously increases distribution of the ana-
lytes into the organic phase, which leads to 
an increase in the extraction efficiency of the 
target analytes. In addition, in the proposed 
method the obtained homogeneous solution 
is broken by dissolving an appropriate 
amount of a salt as the phase separation 
agent. To evaluate this factor, three diverse 
salts including sodium sulfate, potassium 
chloride, and sodium chloride (30 %, w/v, of 
each salt) were studied. The obtained results 
did not show a significant variation (p values 
> 0.05) in the extraction efficiency of the 
target analytes using the mentioned salts. 
But, due to the higher solubility of sodium 
sulfate in the aqueous phase compared to the 
other tested salts, it was selected in this step. 
In order to investigate the effect of salt 
concentration, the concentration of sodium 
sulfate was changed in the range of 20 to 
40 %, w/v. It is obvious that the concentra-
tion of sodium sulfate can affect the volume 
of the separated phase. According to the ob-
tained results, in the cases of 20, 25, 30, 35, 
and 40 ( %, w/v), the volume of the separated 
phase was 0.2, 0.5, 0.9, 1.1, and 1.4 mL, re-
spectively. In all cases, 1.0 mL of that phase 
was used in the subsequent steps, except in 
the cases of concentrations lower than 35 %, 
w/v, in which the volumes of the collected 
phases were lower than 1 mL. In these cases, 
all of the collected phase was removed and 
mixed with appropriate volumes of pure 
ACN in order to reach the final volume of 1 
mL and was used in the other cases. As can 
be seen in Figure 3, extraction efficiency of 
the studied drugs increases by enhancing the 
sodium sulfate concentration up to 35 % 
(w/v) and afterward remain constant consid-
ering p values > 0.05. Hence, 35 % (w/v, so-
dium sulfate) was selected in this step. It is 
noted that in concentrations less than 20 % 
(w/v, sodium sulfate), phase isolation was 
not seen. 
 
Study of pH 
The efficiency of the HLLE based meth-
ods in extracting the analytes which are acid-
ic or basic, may be altered with the change in 
pH of the aqueous solution. In this study, pH 
was studied by varying the pH of the aque-
ous solution from 3 to 12 adjusted by 1 M 
HCl or NaOH solution. 
 
 
Figure 3: Study of phase separation agent concentration. Extraction conditions: are the same as 
those used in Figure 2, except that 2 mL ACN was used as an extraction/disperser solvent. 
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Regarding the results, the extraction effi-
ciency of the selected drugs improved by in-
creasing the aqueous phase pH from 3 to 10 
and afterward remained constant considering 
p values > 0.05. This can be attributed to the 
fact that the selected drugs are much easily 
extracted in their neutral forms compared to 
ionic forms. Regarding the pKa values of the 
selected drugs (Alves et al., 2006), at pHs 
lower than pKa the analytes are in their ionic 
forms due to protonation of amine groups in 
the sample solution and have less tendency 
to be extracted. Therefore, the pH of the 
samples was adjusted at 10.0 in the next ex-
periments. To simplify the pH adjustment, an 
ammoniacal buffer (0.5 M, pH= 10.0) was 
used. 
 
Optimization of DSPE step 
DSPE as a clean–up method may de-
crease the matrix interferences of urine sam-
ples before performing the preconcentration 
step. The efficiency of DSPE in removing 
matrix interferences depends on the type and 
amount of the selected sorbents	 which ad-
sorb interferences and allow the compounds 
of interest to maintain in organic phase. In 
the proposed approach, 1 mL of the ACN 
obtained from SI–HLLE step was transferred 
into a 10–mL glass test tube containing the 
sorbents. The single, dual, and triple systems 
of C18, PSA, and GCB were tested as the 
sorbent for the selected analytes. A single 
system of 50 mg C18, 50 mg PSA, or 25 mg 
GCB did not give sufficient clean chromato-
grams to the urine samples. To improve the 
clean–up effect, the dual and triple sorbent 
systems, including C18–GCB, PSA–GCB, 
C18–PSA, and C18–PSA–GCB were evaluat-
ed. The obtained results indicated that the 
mixture of C18–PSA–GCB was the best 
among the others and removed interfering 
materials efficiently and gave very clean 
chromatograms top the urine samples. So, a 
triple system of the sorbents including 50 mg 
C18, 50 mg PSA, and 25 mg GCB was se-
lected for the subsequent experiments. 
 
Optimization of DLLME–SFO step 
Selection of extraction solvent and its volume 
The extraction solvent has a main effect 
on the extraction capability of analytes in 
DLLME–SFO. In this method, extraction 
solvent should satisfy the following criteria: 
lower density than water, low toxicity, good 
chromatographic behavior, low solubility in 
water, and melting point near to room tem-
perature. Based on these necessities, menthol 
was evaluated as an extractant in this step. 
Menthol (C10H20O), is a green and safe 
(LD50 oral/rat 3300 mg kg–1) organic com-
pound with a density of 0.9 g cm–3 which 
helps it float on the surface of water. It has a 
melting point of 36–38 °C causing its easy 
solidification. Also, it is slightly soluble in 
water. Therefore, menthol was used as an ex-
tractant in the proposed approach.	
Extractant (menthol) volume is another 
main parameter that can influence the extrac-
tion capability and LODs of the method. To 
study the effect of this parameter, different 
volumes of menthol were tested in the range 
of 35–50 μL. According to the obtained re-
sults, ERs of the analytes remained constant 
as menthol volume was enhanced from 35 to 
50 μL. Considering these facts, 35 μL was 
selected in this step. 
 
Optimization of salt effect 
Salt addition is another critical parameter 
that should be optimized. This phenomenon 
can induce a salting out effect in which the 
analyte solubility decreases and as a result, 
the extraction capability of the target ana-
lytes improves. In the present work, sodium 
sulfate was selected to adjust the ionic 
strength of HPLC–grade water due to its 
higher solubility in comparison with other 
salts like potassium chloride, and sodium 
chloride. To study this parameter, various 
concentrations of sodium sulfate (0–10 %, 
w/v) were tested. According to the results, 
ERs of the analytes decreased with the in-
crease in sodium sulfate concentration. So, 
subsequent experiments were conducted 
without using sodium sulfate in this step. 
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Optimization of aqueous phase temperature 
In the suggested approach, diffusion and 
distribution coefficients of the analytes can 
be varied by changing the aqueous solution 
temperature. This phenomenon can help with 
better dispersion of menthol into the aqueous 
solution. Therefore, it can affect the extrac-
tion capability of the selected analytes, so it 
should be optimized. To study this parame-
ter, various experiments were performed in 
the temperature range of 30 to 50 °C. It 
should be noted that at temperatures less 
than 30 °C, the method became useless be-
cause the solution had no turbidity. Accord-
ing to the results, the extraction capability of 
the selected analytes increased up to 40 °C 
and, afterward, remained constant. So, 40 °C 
was used in the subsequent tests. 
 
Evaluation of other parameters 
Centrifugation is a commonly used pro-
cedure to obtain fast isolation of extractant 
droplets from aqueous solution. The effects 
of centrifugation time and rate were investi-
gated in the ranges of 2–6 min and 3000–
6000 rpm, respectively, three times in this 
study. According to the obtained results, 
5000 rpm and 5 min were selected as the 
centrifugation rate and time, respectively in 
all steps. 
In the proposed method, vortex agitation 
was used to improve the contact area be-
tween sorbents and ACN. It was evaluated in 
the range of 0.5 to 3 min. Considering the re-
sults, 2.0 min was selected in this step. 
 
Method validation 
The suggested method was validated by 
evaluating numerous parameters such as lim-
it of detection (LOD), limit of quantification 
(LOQ), accuracy, linearity, selectivity, intra– 
and inter–day precisions, stability, and EFs 
and ERs using international guidelines and 
protocols (U.S. Food and Drug Administra-
tion, 2017; European Medicines Agency, 
2017). 
 
Calibration curves and linearity 
To obtain the linearity of the developed 
approach, matrix–matched calibration curves 
were plotted using peak area versus analytes 
concentrations of the urine sample. The LOD 
and LOQ values were examined on the basis 
of the signal–to–noise ratios (S/N) of 3 and 
10, respectively. Lower limit of quantifica-
tion (LLOQ) was informed as the lowest 
concentration on the calibration curve that 
could be determined with the accuracy of 
80–120 % and the precision of relative 
standard deviation (RSD) ≤ 20 %. Good lin-
earities were obtained with coefficient of de-
termination ≥ 0.996. The LODs, LOQs, and 
LLOQs values are low, which indicate that 
the suggested method can be used to deter-
mine the target analytes in urine. The at-
tained results are indicated in Table 1. 
 
Accuracy and precision 
Accuracy and precision are defined as 
the measurements of the systematic and ran-
dom errors, respectively. Precision stated as 
RSD % was investigated by applying sug-
gested approach on six quality control (QC) 
samples (for intra–day) and four QC samples 
(for inter–day) at the concentration of 10 μg 
L–1 of each drug and ranged from 2–4 % and 
3–6 %, respectively. Accuracy was deter-
mined by added–found method using five 
replicate determinations at 10 μg L–1 level of 
each analyte, and the obtained deviations 
were less than 6 %.  
 
Selectivity 
Evaluating the effects of the compounds 
that can be available in urine to show the ca-
pability of the method in measuring analytes 
in the presence of these components is de-
fined as selectivity. The interference of drugs 
that can potentially be available in urine was 
studied to evaluate matrix exogenous sub-
stances by spiking the blank urine with 10 
mg L–1 of each drug. The drugs tested in the 
selectivity assay were antiepileptic drugs 
(carbamazepine, and valproic acid), anti–
inflammatory drugs (ibuprofen, acetamino-
phen, sodium diclofenac, and naproxen), an-
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Table 1: Quantitative features of the developed method for the selected tricyclic antidepressant drugs 
Analyte LODa) LOQb) LLOQc) LRd) r2e) RSD %f) EF ± SDg) 
ER ± 
SDh) 
      Intraday Interday   
Desipramine 0.26 0.84 0.41 0.84–1000 0.997 3 5 
375 ± 
15 75 ± 3 
Nortriptyline 0.24 0.79 0.40 0.79–1000 0.998 4 6 
380 ± 
25 76 ± 5 
Imipramine 0.31 1.1 0.56 1.1–1000 0.996 4 4 
345 ± 
20 69 ± 4 
Amitriptyline 0.22 0.71 0.35 0.71–1000 0.997 2 3 
420 ± 
15 84 ± 3 
Clomipramine 0.29 0.93 0.45 0.93–1000 0.997 3 4 
405 ± 
25 81 ± 5 
a) Limit of detection (S/N=3) (µg L–1) 
b) Limit of quantification (S/N=10) (µg L–1) 
c) Lower limit of quantification (S/N=5) (µg L–1) 
d) Linear range (µg L–1) 
e) Square of correlation coefficient 
f) Relative standard deviation for intra– (n=6) and for inter–day (n=4) precisions at a concentration of 10 µg L–1 of each analyte 
g) Enrichment factor ± standard deviation (n=3) 
h) Extraction recovery ± standard deviation (n=3) 
 
 
tiarrhythmic drugs (propranolol, metoprolol, 
verapamil, and carvedilol), and antidepres-
sants (trimipramine, doxepine, and paroxe-
tine). The obtained results confirmed that 
there is no endogenous interference in the re-
tention times related to the evaluated ana-
lytes. Responses of the analytes at the LLOQ 
concentrations were compared with the re-
sponses of the samples spiked with men-
tioned drugs. No interference from the men-
tioned drugs was observed for the studied 
analytes. These results indicate that the pro-
posed method is selective for the analysis of 
analytes in urine.  
 
Stability 
To evaluate the stability of the selected 
drugs in the urine samples, the blank urine 
was spiked with drugs at the concentrations 
of 50 and 100 μg L–1 (each drug, n=3). In 
this work, short– and long–term stabilities 
were determined by analyzing the samples 
kept at room temperature (24 °C) for 12 
hours and stored at –20 °C for 5 days, re-
spectively. The freeze–thaw stability of the 
analytes was also determined after three 
freeze and thaw (–20 to 24 °C) cycles. The 
obtained results were compared with those of 
freshly prepared samples and were expressed 
in RSD %. The obtained RSD % were less 
than 7 %, which indicates good stability of 
the selected drugs in urine under the studied 
conditions. 
 
Calculation of EFs and ERs 
EF is stated as the ratio between the ana-
lyte concentration in the collected organic 
phase (Ccoll) and the initial concentration of 
the analyte (C0) in aqueous solution. 
ܧܨ ൌ ܥ௖௢௟௟ ܥ଴ൗ 																																																	ሺ1ሻ 
ER is stated as the percentage of the total 
analyte amount (n0) that is extracted into col-
lected phase (ncoll): 
ܧܴ ൌ ௡೎೚೗೗௡బ ൈ 100 ൌ
஼೎೚೗೗ൈ௏೎೚೗೗
஼బൈ௏ೌ ೜ ൈ 	100 ൌ
ܧܨ ൈ ௏೎೚೗೗௏ೌ ೜ 	ൈ 100                                       (2) 
In this equation Vcoll and Vaq are volumes 
of the collected phase and sample solution, 
respectively. High EFs (345–420) and good 
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ERs (69–84 %) were obtained in this study 
(Table 1). 
 
Study of matrix effect  
To evaluate the matrix effect in the urine 
sample, the added–found method was used. 
The blank urine sample was spiked with the 
selected analytes at three concentration lev-
els (10, 50, and 100 µg L−1 of each analyte) 
and the suggested method was applied to it 
for triplicate. In this step, the results obtained 
for the evaluated drugs in the urine sample 
are compared with those attained for HPLC–
grade water spiked at same concentrations 
and expressed as relative recoveries (Table 
2). Regarding the results, the suggested 
method indicates good recoveries in the 
urine sample ranging from 84 to 97 % and is 
relevant and applicable for the determination 
of target drugs in urine.  
 
Table 2: Study of matrix effect by the proposed 
method in the blank urine sample spiked at dif-
ferent concentration levels.  
Mean relative  
recovery ±  
standard  
deviation (n=3)
Spiked level 
(µg L-1) 
 
Analyte 
88 ± 2 10 Desipramine 
94 ± 3 50 
93 ± 3 100 
93 ± 4 10 Nortriptyline 
96 ± 5 50 
97 ± 4 100 
84 ± 3 10 Imipramine 
90 ± 5 50 
93 ± 3 100 
87 ± 2 10 Amitriptyline 
91 ± 1 50 
95 ± 3 100 
89 ± 2 10 Clomipra-
mine 94 ± 4 50 
97 ± 3 100 
 
 
Real samples analysis 
To evaluate the applicability of the intro-
duced approach, the urine samples of three 
depressed female patients who are being 
treated with amitriptyline tablets (25 mg, 
twice a day), nortriptyline (25 mg, twice a 
day), and clomipramine (50 mg, once a day), 
respectively, were analyzed. In addition, the 
suggested approach was applied to the analy-
sis of urine samples of two depressed male 
patients treated with desipramine (25 mg, 
twice a day) and imipramine (25 mg, twice a 
day), respectively. Figure 4 shows HPLC–
UV chromatograms of these samples after 
applying the suggested approach as well as 
the blank urine sample and direct injection of 
a standard solution of analytes (20 mg L–1 of 
each analyte) in methanol. After three deter-
minations of each sample using standard ad-
dition method, the detected concentrations of 
amitriptyline, nortriptyline, desipramine, 
clomipramine, and imipramine in the evalu-
ated urine samples were 35 ± 2, 38 ± 4, 29 ± 
2, 39 ± 3, and 40 ± 4 µg L–1, respectively.  
 
CONCLUSION 
In this study, a green and efficient ap-
proach (SI–HLLE–DSPE–DLLME–SFO) 
was developed for the extraction of some 
TCAs in urine samples prior to their deter-
mination by HPLC–UV. Throughout the 
proposed method, no toxic organic solvent 
was used. Small volumes of non–toxic sol-
vents like ACN and menthol were consumed 
and helped decrease the risk for human 
health and environment. The validation re-
sults indicated high sensitivity, accuracy, and 
precision for the suggested approach. The 
proposed procedure could be applied as an 
efficient analytical method in further TCAs 
pharmacokinetic and forensic studies. 
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Figure 4: Typical HPLC–DAD chromatograms 
of: (A) standard solution of the selected analytes 
at a concentration of 20 mg L–1 of each analyte 
(direct injection), (B) blank urine sample spiked 
with 50 µg L−1 of each analyte, (C) urine sample 
of a female patient treated with amitriptyline, (D) 
urine sample of a female patient treated with 
nortriptyline, (E) urine sample of a male patient 
treated with desipramine, (F) urine sample of a 
male patient treated with imipramine, and (G) 
urine sample of a female patient treated with 
clomipramine. Detection wavelength was 230 
nm. For more chromatographic conditions see 
the experimental section. Peaks identification: 1) 
desipramine, 2) nortriptyline, 3) imipramine, 4) 
amitriptyline, and 5) clomipramine. 
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